SCHEMBL5320940

SCHEMBL5320940

C=CCSCC(O)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11879501 0.96 ALOX5 (0.42)
SCHEMBL11023540 0.87 ALOX5 (0.53)
Diallyl Sulfide SCHEMBL9376569 0.85 ALOX5 (0.58)
SCHEMBL11881950 0.84 CA1 (0.36)
SCHEMBL9374822 0.81 ALOX5 (0.46)
SCHEMBL11878098 0.80 ALOX5 (0.40)
SCHEMBL5613863 0.79
SCHEMBL11880486 0.79
SCHEMBL27615249 0.79
SCHEMBL890790 0.76 LMNA (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011011710-A1 METHODS OF TREATING VIRAL INFECTIONS CHIMERIX, INC. (US) 2011-01-27 WO claimed
EP-0043472-A1 3-Hydrocarbylthio-2-acyloxypropyl 2-trimethylammonioethyl phosphates, process for producing the same and pharmaceutical preparations containing the same A. Nattermann & Cie. GmbH (DE) 1982-01-13 EP claimed
EP-2841162-A1 A METHOD OF MITIGATING VIRUS ASSOCIATED END-ORGAN DAMAGE Chimerix, Inc. (US) 2015-03-04 EP disclosed
EP-2770834-A1 HEXADECYLOXYPROPYL CIDOFOVIR FOR THE TREATMENT OF DOUBLE-STRANDED DNA VIRUS INFECTION Chimerix, Inc. (US) 2014-09-03 EP disclosed
WO-2013163509-A1 A METHOD OF MITIGATING VIRUS ASSOCIATED END-ORGAN DAMAGE CHIMERIX, INC. (US) 2013-10-31 WO disclosed
WO-2013062119-A1 CURABLE COMPOSITION DOW CORNING TORAY CO., LTD. (JP) 2013-05-02 WO disclosed
WO-2013063436-A1 HEXADECYLOXYPROPYL CIDOFOVIR FOR THE TREATMENT OF DOUBLE-STRANDED DNA VIRUS INFECTION CHIMERIX, INC. (US) 2013-05-02 WO disclosed
EP-1868628-A2 COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF POXVIRUS INFECTIONS Chimerix, Inc. (US) 2007-12-26 EP disclosed
WO-2006110655-A2 COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF POXVIRUS INFECTIONS CHIMERIX, INC. (US) 2006-10-19 WO disclosed
US-5851548-A Liposomes containing cationic lipids and vitamin D GEN-PROBE INCORPORATED (US) 1998-12-22 US disclosed
US-5759519-A Method for the intracellular delivery of biomolecules using thiocationic lipids GEN-PROBE INCORPORATED (US) 1998-06-02 US disclosed
US-5711964-A CELLULAR METABOLISM AND CATIONIC LIPIDS UNITED STATES OF AMERICA (US) 1998-01-27 US disclosed
WO-1996040627-A2 THIOCATIONIC LIPIDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF GEN-PROBE INCORPORATED (US) 1996-12-19 WO disclosed
EP-0747351-A2 Thiocationic lipids, pharmaceutical compositions and methods of use thereof GEN-PROBE INCORPORATED (US) 1996-12-11 EP disclosed
EP-0043472-B1 3-HYDROCARBYLTHIO-2-ACYLOXYPROPYL 2-TRIMETHYLAMMONIOETHYL PHOSPHATES, PROCESS FOR PRODUCING THE SAME AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME A. Nattermann & Cie. GmbH (DE) 1983-07-20 EP disclosed
EP-0043472-A1 3-Hydrocarbylthio-2-acyloxypropyl 2-trimethylammonioethyl phosphates, process for producing the same and pharmaceutical preparations containing the same A. Nattermann & Cie. GmbH (DE) 1982-01-13 EP disclosed
US-4087466-A NONIONIC SURFACTANTS L'OREAL (FR) 1978-05-02 US disclosed
US-4058629-A Polyhydroxyl monosulfoxide shampoo compositions L'OREAL (FR) 1977-11-15 US disclosed
US-3984480-A Polyhydroxyl monosulfoxide surfactant L'OREAL (FR) 1976-10-05 US disclosed
US-3966398-A Hair dyeing composition containing a non-ionic surfactant L'OREAL (FR) 1976-06-29 US disclosed